Product Details
GRANIX 300 MCG/0.5 ML SAFE SYR
Manufacturer: TEVA PHARMACEUTICALS USA
MFG#: 63459-0910-11
NDC: 63459-0910-11
PID: 639452
1/UN
$95.25
In StockAdditional Information
| Product Name | Granix 300 Mcg/0.5 Ml Safe Syr |
| Active Ingredient | Tbo-filgrastim |
| Drug Class | Granulocyte Colony-Stimulating Factor (G-CSF) |
| Mechanism of Action | Stimulates proliferation and differentiation of neutrophil progenitors by binding to G-CSF receptors |
| Strength | 300 mcg/0.5 mL |
| Dosage Form | Solution for injection |
| Route of Administration | Subcutaneous |
| Side Effects | Bone pain, headache, injection site reaction, fatigue, fever, splenomegaly |
| Precautions | Monitor for splenic rupture, allergic reactions, leukocytosis, respiratory distress |
| Storage | Refrigerate at 2–8°C (36–46°F); do not freeze; protect from light |
| Packaging | Prefilled, single-dose safety syringe |
| Uses | Reduce duration of severe neutropenia in patients receiving myelosuppressive chemotherapy |
Description
Granix (Tbo-filgrastim) 300 mcg/0.5 mL is a sterile, preservative-free solution administered via prefilled syringe for subcutaneous injection. It is classified as a granulocyte colony-stimulating factor (G-CSF) and is used to stimulate the production of neutrophils, a type of white blood cell essential for fighting infections. Each prefilled syringe contains 300 micrograms of Tbo-filgrastim in 0.5 mL of solution.
This medication is indicated for use in patients with non-myeloid malignancies who are receiving myelosuppressive chemotherapy associated with a significant risk of febrile neutropenia. By enhancing neutrophil production in the bone marrow, Granix reduces the duration of severe neutropenia and the incidence of febrile neutropenia following chemotherapy.
The mechanism of action involves binding to specific G-CSF receptors on hematopoietic cells, promoting proliferation, differentiation, and activation of neutrophil progenitor cells. The response results in increased neutrophil counts, typically observed within days of administration.
Frequently Asked Questions (FAQs)
The cost of GRANIX 300 MCG/0.5 ML SAFE SYR is $$95.25
GRANIX 300 MCG/0.5 ML SAFE SYR is manufactured by TEVA PHARMACEUTICALS USA.
You can purchase GRANIX 300 MCG/0.5 ML SAFE SYR on our website at https://supplies.pipelinemedical.com/product/detail/granix-300-mcg-0-5-ml-safe-syr-639452